|
 |
 |
Contract research and consultation, from Alpha Genesis, Inc.
AGI maintains a team of dedicated professional staff to develop and execute a variety of nonhuman primate contract research applications. Because of our extensive experience and ready-access to the most...
|
| |
|
 |
Primate Housing and CDC Quarantine, from Alpha Genesis, Inc.
AGI provides enriched housing facilities for nonhuman primates in both CDC quarantine and non-quarantine settings on a cost-effective per diem basis. Buy and board agreements ensure long-term on-demand...
|
| |
|
|
 |
Baculovirus Expression, from Blue Sky Biotech, Inc.
Insect cells are the preferred module for high-level recombinant protein expression of many disease-relevant protein families. Several popular kit systems exist in the protein expression marketplace, however...
|
| |
|
 |
Custom Monoclonal Antibodies for Research Purposes, from MorphoSys AG
Custom monoclonal antibodies are generated for non-therapeutic applications using the HuCAL technology. The HuCAL technology allows novel antibodies to be generated significantly faster than the current...
|
| |
|
 |
Custom Therapeutic Antibody Generation, from MorphoSys AG
For collaboration partners requiring fully human antibodies directed against their targets for further development as therapeutics, MorphoSys provides highly optimized antibodies according to its partners’...
|
| |
|
 |
Molecular Biology, from Blue Sky Biotech, Inc.
Molecular Biology Services
Gene synthesis
Sub cloning and plasmid construction
Vector construction and modification
Construct generation
Site-directed mutagenesis
Genetic (cDNA) cloning
In...
|
| |
|
|
|
 |
Protein Sciences and Protein Purification, from Blue Sky Biotech, Inc.
Protein Sciences and Protein Purification
FPLC: IEC, IMA, SEC, AC, Buffer-exchange, etc.
Microsome preparation
Tissue/organ extraction and purification
Antibody purification
Development of multi-step...
|
| |
|
|
|
 |
Tissue Culture & Fermentation, from Blue Sky Biotech, Inc.
Tissue Culture & Fermentation
Scale-up of E. coli in 10-L/55-L bioreactors
Scale-up of yeasts in multiple 10-L bioreactors
Scale-up of insect-cell and mammalian expression in bioreactors
Optimization...
|
| |
